For research use only. Not for therapeutic Use.
Bromo-PEG4-MS is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1].
| Catalog Number | I045416 |
| CAS Number | 2167807-41-0 |
| Synonyms | 2-[2-[2-(2-bromoethoxy)ethoxy]ethoxy]ethyl methanesulfonate |
| Molecular Formula | C9H19BrO6S |
| Purity | ≥95% |
| InChI | InChI=1S/C9H19BrO6S/c1-17(11,12)16-9-8-15-7-6-14-5-4-13-3-2-10/h2-9H2,1H3 |
| InChIKey | LUIMQGOWWSFHND-UHFFFAOYSA-N |
| SMILES | CS(=O)(=O)OCCOCCOCCOCCBr |
| Reference | [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
